Maven Securities’s Privia Health PRVA Stock Holding History

Maven Securities’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-200,000	Closed	-$5.22M	–	1207
2023 Q2	$5.22M	Buy	+200,000	New	+$5.28M	0.08%	126

Other funds holding PRVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Maven Securities's PRVA Position: Q3 2023 in Review

Maven Securities sold out of Privia Health (PRVA) in Q3 2023, closing a stake of 200,000 shares — an estimated $5.22M sold.

Maven Securities first reported a position in PRVA in Q2 2023 and held it in 1 quarter. The position peaked at $5.22M in Q2 2023. 218 funds tracked by Wall St. Rank hold PRVA as of Q3 2023.

Maven Securities reported no remaining Privia Health position as of Q3 2023 after selling out during the quarter.
Maven Securities sold 200,000 Privia Health shares in Q3 2023, an estimated $5.22M.
Maven Securities first reported a position in Privia Health in Q2 2023 and held it in 1 quarter.
Maven Securities's Privia Health position peaked at $5.22M in Q2 2023.
218 funds tracked by Wall St. Rank held Privia Health as of Q3 2023.

Based on Maven Securities's 13F filing for Q3 2023, filed 13 Nov 2023.